iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Sees Large Decrease in Short Interest

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) was the target of a large decline in short interest in August. As of August 31st, there was short interest totaling 11,634 shares, a decline of 60.5% from the August 15th total of 29,452 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 9,943 shares, the days-to-cover ratio is presently 1.2 days.

iShares LifePath Target Date 2045 ETF Price Performance

Shares of NYSEARCA:ITDE traded down $0.18 on Tuesday, hitting $40.02. The company’s stock had a trading volume of 14,377 shares, compared to its average volume of 13,758. The company has a 50-day simple moving average of $40.35 and a 200 day simple moving average of $39.02. The company has a market capitalization of $88.04 million, a PE ratio of 20.03 and a beta of 0.81. iShares LifePath Target Date 2045 ETF has a 1 year low of $34.81 and a 1 year high of $41.23.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.